# A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

> **NCT06402981** · — · RECRUITING · sponsor: **Zhejiang University** · enrollment: 2000 (estimated)

## Conditions studied

- Immune Checkpoint Inhibitors
- Liver Injury

## Interventions

- **OTHER:** High risk prediction model for liver injury

## Key facts

- **NCT ID:** NCT06402981
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06402981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06402981, "A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06402981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*